REDWOOD CITY, Calif. – Biotricity is preparing to add its Biopatch to the portfolio of telehealth and remote patient monitoring devices that is creating a shift in health care delivery to outpatient care.
Biotricity expects to release its Biopatch electrocardiogram wearable patch, which provides wireless arrhythmia monitoring for patients who are either at risk for, or diagnosed with, certain cardiac issues, early next year.
“With the right technology and infrastructure, physicians can care for many patients remotely,” said Waqaas Al-Siddiq, CEO Biotricity. “The intersection of new technology and the patient-consumer is driving health care offerings to become more diversified, while also delivering enhanced care at a lower cost.”
By 2020, an estimated 36 million patients will be remotely monitored by devices like the Biopatch and others, according to research by market research firm Berg Insight.
As care moves out of the hospital and into the home, interoperability will be key to ensuring quality care and positive outcomes.
“Care coordination and communication must be synchronized, and tests, procedures and results have to be available to everyone in the chain of outpatient care,” said Al-Siddiq. “When patient data is collected in real time and stored on the Cloud, physicians from various points of care can access this information. Combined with a patient’s medical history, which can also be stored on the Cloud, physicians and care centers are better equipped to offer faster, more accurate diagnoses.”
Ultimately, patients today are consumers that insist on having options and making informed decisions about their health care, said Al-Siddiq. The shift to outpatient care caters to the patient-consumer, because it aims to offer patients options that can give them convenient access to the closest location that can care for them.
“Informed patients with options are engaged patients, and engaged patients take a more proactive role in the management of their own health,” he said.